دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
دانلود کتاب Ambulatory Peritoneal Dialysis
دانلود کتاب دیالیز صفاقی سرپایی
مشخصات کتاب
Ambulatory Peritoneal Dialysis
ویرایش: 1 نویسندگان: M. M. Avram, D. Burrell, P. A. Slater, P. A. Fein, A. Antignani, N. Mittman, D. Tan (auth.), Morrell M. Avram M.D., F.A.C.P., Carmelo Giordano M.D., Natale G. DeSanto M.D., Neal Mittman M.D., Giorgio Bazzato, Paul A. Fein M.D., Amado Gan M.D., Philip Goldwasser M.D., Paul A. Slater M.D. (eds.) سری: ISBN (شابک) : 9781461595571, 9781461595557 ناشر: Springer US سال نشر: 1990 تعداد صفحات: 342 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 12 مگابایت
قیمت کتاب (تومان) : 41,000
کلمات کلیدی مربوط به کتاب دیالیز صفاقی سرپایی: داخلی، طب عمومی/پزشکی خانواده، نفرولوژی، اورولوژی/آندرولوژی
در صورت تبدیل فایل کتاب Ambulatory Peritoneal Dialysis به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب دیالیز صفاقی سرپایی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
توضیحاتی در مورد کتاب دیالیز صفاقی سرپایی
چهارمین کنگره بین المللی دیالیز صفاقی در ونیز ایتالیا از 29 ژوئن تا 2 ژوئیه 1987 برگزار شد. در این زمان دیالیز صفاقی به عنوان درمانی برای بخش قابل توجهی از بیماران مبتلا به بیماری کلیوی در مرحله نهایی و تعداد بیشماری ظهور کرده بود. بیماران مبتلا به نارسایی حاد کلیه این درمان در حال حاضر در سراسر جهان انجام می شود و درمان پایدار برای حدود 40000 بیمار مبتلا به نارسایی مزمن کلیه است که 15 تا 20 درصد از درمان دیالیز در حدود 1000 مرکز را شامل می شود. بنابراین، تعجب آور نیست که تعداد متخصصان بهداشتی که در تحقیقات و کاربرد این درمان درگیر هستند نیز به طور تصاعدی افزایش یافته است. اولین سمپوزیوم بین المللی دیالیز صفاقی، که توسط دکتر A. Treviiio-Be cerra در Chapala، مکزیک، در سال 1978 سازماندهی شد، گروهی از پیشگامان را در زمانی که دیالیز صفاقی سرپایی مستمر در مراحل اولیه بود گرد هم آورد. در سال 1981، دکتر G. M. Gahl ریاست دومین سمپوزیوم در برلین غربی را بر عهده داشت، زمانی که تکنیک و علاقه حرفه ای به طور قابل توجهی در حال رشد بود. در سال 1984، زمانی که دکتر 1. F. Winchester و من سومین سمپوزیوم را سازماندهی کردیم، مقالات ارائه شده از 100 فراتر رفت و حدود 1000 شرکت کننده وجود داشت. در آن زمان مناسب تشخیص داده شد که یک گروه سازمان یافته تر تشکیل شود و انجمن بین المللی دیالیز صفاقی تأسیس شد. یکی از اولین اقدامات انجمن انتخاب از بین چندین متقاضی دکتر
بودتوضیحاتی درمورد کتاب به خارجی
The Fourth International Congress of Peritoneal Dialysis was held in Venice, Italy, June 29 to July 2, 1987. By this time peritoneal dialysis had emerged as a treatment for a substantial fraction of patients with end-stage renal disease and countless numbers of patients with acute renal failure. This treatment is now practiced worldwide and is the life-sustaining treatment for about 40,000 patients with chronic renal failure, representing 15 to 20% of dialysis therapy in about 1000 centers. It is not surprising, therefore, that the number of health professionals engaged in the investigation and the application of the treatment has also grown exponen tially. The First International Symposium on Peritoneal Dialysis, organized by Dr. A. Treviiio-Be cerra in Chapala, Mexico, in 1978, brought together a group of pioneers when continuous ambulatory peritoneal dialysis was in its infancy. In 1981, Dr. G. M. Gahl chaired the Second Symposium, in West Berlin, when the technique and professional interest were growing con siderably. By 1984, when Dr. 1. F. Winchester and I organized the Third Symposium, the pre sented papers exceeded 100 and there were about 1000 attendees. At that time, it was deemed appropriate to form a more organized group and the International Society for Peritoneal Dialy sis was founded. One of the first actions of the Society was to choose from among several applicants Dr.
فهرست مطالب
Front Matter....Pages i-xvi
Front Matter....Pages 1-1
The Role of Cholesterol and Lipids in the Atherogenicity of Continuous Ambulatory Peritoneal Dialysis Patients Update 1990....Pages 3-10
Erythropoietin in Continuous Ambulatory Peritoneal Dialysis Patients, 1990 Benefits of the Subcutaneous Route in the First U. S. Experience....Pages 10-14
Solving the Major Problems of Continuous Ambulatory Peritoneal Dialysis....Pages 15-17
Functional and Histological Changes of Peritoneal Membrane in Long-Term Continuous Ambulatory Peritoneal Dialysis....Pages 18-23
Where Are We Going?....Pages 24-27
Front Matter....Pages 29-29
Peritoneal Ultrafiltration Less Efficient with Prolonged Dwell or Excessive Dialysate Dextrose....Pages 31-35
Neostigmine Increases Net Ultrafiltration and Solute Clearances in Peritoneal Dialysis by Reducing Lymphatic Absorption....Pages 36-39
Phosphatidylcholine Increases Ultrafiltration in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 39-41
Effect of Cationic Molecules on the Permeability of the Mesothelium in Vitro....Pages 42-44
Phosphatidylcholine A Physiological Modulator of the Peritoneal Membrane....Pages 44-47
Ultrafiltration Loss in Continuous Ambulatory Peritoneal Dialysis Patients Effects of Intraperitoneal Therapy with Calcium Antagonists....Pages 48-52
A Chemoattractant in Peritoneal Effluent from Continuous Ambulatory Peritoneal Dialysis Patients....Pages 52-56
The Isolation and Culture of Human Mesothelial Cells Characterization of Cyclooxygenase Products....Pages 56-59
Beta-Blockers Induce Functional Changes That Potentially Injure the Peritoneum in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 60-63
Loss of Mesothelial and Microvascular Fixed Anionic Charges during Murine Experimentally Induced Septic Peritonitis....Pages 63-66
Role of Blood Osmolality in the Regulation of Vasopressin Secretion in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 66-71
Lymphatic Absorption in Continuous Ambulatory Peritoneal Dialysis Patients with Normal and High Transperitoneal Glucose Transport....Pages 71-75
The Kinetics of Ultrafiltration during Peritoneal Dialysis in Rats The Role of Lymphatics....Pages 76-78
Dihydroergotamine Lowers Peritoneal Transfer Rates A Hypovolemic Transport Decrease....Pages 79-82
Ultrafiltration Patterns of Dextran and Hydroxyethylstarch during Long-Dwell Peritoneal Dialysis Exchanges in Nonuremic Rats....Pages 83-86
Front Matter....Pages 29-29
Peritoneal Clearances, Ultrafiltration, and Diuresis in Long-Term Continuous Ambulatory Peritoneal Dialysis....Pages 87-90
Effect of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis on the Transport of Inhibitory Factors of Lymphocyte Proliferation Present in Uremic Serum....Pages 91-92
Methotrexate Influences Peritoneal Permeability....Pages 93-97
High Doses of Intraperitoneal Furosemide in Long-Dwell Exchange....Pages 97-100
Calcium Peritoneal Mass Transfer in Continuous Ambulatory Peritoneal Dialysis....Pages 101-103
Structural Changes in Peritoneal Vessels during Continuous Ambulatory Peritoneal Dialysis A Model for the Study of Diabetic Microangiopathy....Pages 103-109
Mesothelial Hyperplasia after Chronic Intraperitoneal Fluid Administration A Light Microscopy Study in the Rat....Pages 110-112
Mitogenic Effect of the Peritoneal Effluent on Mice Fibroblast Cultures in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 112-115
Oxygen Metabolism of Peritoneal Phagocytes....Pages 115-118
Front Matter....Pages 119-119
The Nutritional Status of Long-Term CAPD Patients....Pages 121-124
Renal Osteodystrophy Bone Mineral Density Loss and Recovery with Treatment....Pages 124-128
Bone Mineralization Defect in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 129-133
Faster Energy Turnover in Peritoneal Dialysis....Pages 133-136
Front Matter....Pages 137-137
One-Year Experience with Swan-Neck Missouri 2 Catheter....Pages 139-142
Thallium 201 Myocardial Imaging in Continuous Ambulatory Peritoneal Dialysis Patients at High Risk of Coronary Artery Disease....Pages 142-144
Tidal Peritoneal Dialysis....Pages 145-149
Absorption of Inulin and High-Molecular-Weight Gelatin Isocyanate Solutions from Peritoneal Cavity of Rats....Pages 149-152
Technical Developments in Continuous Ambulatory Peritoneal Dialysis Summary of Personal Experiences....Pages 152-154
The Use of Hyposmolar Glucose Polymer Solution in Continuous Ambulatory Peritoneal Dialysis A Seven-Day Study....Pages 155-159
Loss of Ultrafiltration Capacity Role of Plasticizers....Pages 159-166
Front Matter....Pages 137-137
Chronic Peritoneal Dialysis Using Curled Catheters....Pages 166-169
Front Matter....Pages 171-171
Immune Defense and Peritonitis in Continuous Ambulatory Peritoneal Dialysis....Pages 173-175
Peritoneal Macrophages of Patients on Continuous Ambulatory Peritoneal Dialysis Show Alterations in Sensitivity and Secretion of Prostaglandins during Peritonitis....Pages 175-181
Interferon Abnormalities and Peritonitis in Continuous Ambulatory Peritoneal Dialysis....Pages 181-186
Association of Staphylococcus aureus Nasal Carriage with Staphylococcus aureus Catheter Exit-Site Infections....Pages 186-188
Survival and Growth of Staphylococcus epidermidis within Phagocytes in Relation to Recurrent Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 189-193
Does Viral Infection Predispose to Peritonitis in Continuous Ambulatory Peritoneal Dialysis?....Pages 193-195
Peritonitis: The Most Serious Complication of Continuous Ambulatory Peritoneal Dialysis Results of a Multi-Center Study....Pages 196-198
Generation and Release of Eicosanoids and Proteolytic Enzymes by Human Peritoneal Macrophages in Response to Staphylococcus epidermidis and the Calcium Ionophore A23187....Pages 199-203
Humoral and Cellular Host-Defense Factors and Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 204-208
Continuous Ambulatory Peritoneal Dialysis Host Defenses and Staphyloccus aureus Role of Opsonins, Fibronectin, Fibrinogen, and Fibrin....Pages 209-213
Long-Term Experience with the Y-Connector in Peritonitis Prevention in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 213-216
Inhibition of Binding of Escherichia coli to Human Peritoneal Macrophages by Peritoneal Effluent from Patients on Peritoneal Dialysis....Pages 217-220
Use of Exudate Smears for Diagnosis of Peritoneal Catheter Exit-Site Infection....Pages 220-222
Early Bacteriological Diagnosis of Continuous Ambulatory Peritoneal Dialysis Peritonitis with the Use of a Cytocentrifuge....Pages 223-226
Front Matter....Pages 227-227
USA CAPD Registry 1987 Report Highlights....Pages 229-231
Multi-Center Study of Outcome of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis Patients A 4-Year Analysis....Pages 232-234
Peritoneal Membrane Function in Myeloma....Pages 235-238
Risk Factors and Outcome of Diabetics on Continuous Ambulatory Peritoneal Dialysis....Pages 238-240
Survival of the “Ideal” Continuous Ambulatory Peritoneal Dialysis Patient....Pages 241-244
Front Matter....Pages 227-227
Efficacy of Hepatitis B Vaccine in Continuous Ambulatory Peritoneal Dialysis Patients Is Influenced by Blood Transfusion....Pages 245-248
Stable Continuous Ambulatory Peritoneal Dialysis Patients Assess the Suitability of New Candidates....Pages 248-250
Individualization of Exchange Volume to Optimize Continuous Ambulatory Peritoneal Dialysis....Pages 251-253
Postural Hypotension with Glucose Ingestion in Patients on Continuous Ambulatory Peritoneal Dialysis....Pages 254-256
Impact of Increasing Intraperitoneal Volume on Left Ventricular Function in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 256-259
Continuous Cycling Peritoneal Dialysis Wet Is Better Than Dry....Pages 259-263
Comparative Evaluation of Hemodialysis and Continuous Ambulatory Peritoneal Dialysis A Multi-Center Study....Pages 264-266
Continuous Ambulatory Peritoneal Dialysis for the AIDS Patient....Pages 266-269
Comparative Study of Muzolimine and Furosemide in Continuous Ambulatory Peritoneal Dialysis Patients....Pages 269-272
Successful Joint Care of Continuous Ambulatory Peritoneal Dialysis Patients with Two District General Hospitals....Pages 272-273
The Benefits of Long-Life Tubing in Continuous Ambulatory Peritoneal Dialysis....Pages 274-276
Effect of Protein or Amino Acid Supplementation on the Nutritional Status of Patients on Continuous Ambulatory Peritoneal Dialysis....Pages 276-280
New Strategy following Peritoneal Catheter Implantation in Continuous Ambulatory Peritoneal Dialysis....Pages 280-282
Treatment of Refractory Congestive Heart Failure by Continuous Ambulatory Peritoneal Dialysis....Pages 283-286
Vitamin Deficiencies in Continuous Ambulatory Peritoneal Dialysis Patients Effects of Supplementation....Pages 287-293
Leakage of Dialysate across the Diaphragm....Pages 294-297
Continuous Ambulatory Peritoneal Dialysis — An Adequate Therapy in Developing Countries....Pages 298-301
Front Matter....Pages 303-303
Acute Peritoneal Dialysis in Premature and Newborn Infants....Pages 305-308
Peritoneal Dialysis in Acute Renal Failure in the Neonate Limits and Complications....Pages 309-311
The Optimal Dialysis Regimen for Children Undergoing Different Continuous Cycling Peritoneal Dialysis Protocols....Pages 311-315
Front Matter....Pages 303-303
Intracellular Amino Acids in Children on Continuous Ambulatory Peritoneal Dialysis....Pages 315-317
Efficiency of High-Volume Continuous Ambulatory Peritoneal Dialysis in Children....Pages 318-320
Outpatient Cycler Peritoneal Dialysis for Home Failure, Hemodialysis Failure, AV Access Failure, and Cardiovascular Instability....Pages 321-323
Back Matter....Pages 325-340
